112
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Lack of association between the ATP13A2 A746T variant and Parkinson's disease susceptibility in Han Chinese: a meta-analysis

, , , , , & show all
Pages 593-599 | Received 07 Jan 2015, Accepted 25 Mar 2015, Published online: 05 Jun 2015

References

  • Lesage S, Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 2009;18(R1):R48–59.
  • Valente EM, Salvi S, Ialongo T, et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 2004;56(3):336–41.
  • Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44(4):601–7.
  • Lin CH, Tan EK, Chen ML, et al. Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore. Neurology 2008;71(21):1727–32.
  • Ramirez A, Heimbach A, Grundemann J, et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 2006;38(10):1184–91.
  • Chen CM, Lin CH, Juan HF, et al. ATP13A2 variability in Taiwanese Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 2011;156b(6):720–9.
  • Fei QZ, Cao L, Xiao Q, et al. Lack of association between ATP13A2 Ala746Thr variant and Parkinson's disease in Han population of mainland China. Neurosci Lett 2010;475(2):61–3.
  • Chan AY, Baum L, Tang NL, et al. The role of the Ala746Thr variant in the ATP13A2 gene among Chinese patients with Parkinson's disease. J Clin Neurosci 2013;20(5):761–2.
  • Wang F, Wang TF, Yang XL. Association between Parkinson's disease and ATP13A2 Ala746Thr variant. Chin J Exp Surg 2013;30(4):842–4.
  • Funayama M, Tomiyama H, Wu RM, et al. Rapid screening of ATP13A2 variant with high-resolution melting analysis. Mov Disord 2010;25(14):2434–7.
  • Vilarino-Guell C, Soto AI, Lincoln SJ, et al. ATP13A2 variability in Parkinson disease. Hum Mutat 2009;30(3):406–10.
  • Djarmati A, Hagenah J, Reetz K, et al. ATP13A2 variants in early-onset Parkinson's disease patients and controls. Mov Disord 2009;24(14):2104–11.
  • Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55(3):181–4.
  • Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56(1):33–9.
  • Wang XD. Standard for diagnosing and distinguishing Parkinson's disease and Parkinsonian syndromes. Chin J Nerv Ment Dis 1984;18:256–7.
  • The Writing Group of the Movement Disorders and Parkinson's Disease Society of Neurology Committee of Chinese Medical Association. The dssssiagnosis of Parkinson's disease. Chin J Neurol 2006;39:408–9.
  • Zhang TS, Zhong WZ. Applied methodology for evidence-based medicine. Changsha, Hunan Province: Central South University Press; 2012.
  • Thakkinstian A, McElduff P, D’Este C, et al. A method for meta-analysis of molecular association studies. Stat Med 2005;24(9):1291–306.
  • Egger M, Smith G, Altman D. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Books; 2001.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Br Med J 2003;327(7414):557–60.
  • Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. Br Med J 1997;315(7121):1533–7.
  • Zhu L, Zhou Y, Li F, et al. Lack of association between three snps on PARK9, PARK15 and BST1 genes and Parkinson's disease in Northern Han Chinese population. Parkinsonism Relat Disord 2012;18SUPPL:2(S176–).
  • Mao XY, Burgunder JM, Zhang ZJ, et al. ATP13A2 G2236A variant is rare in patients with early-onset Parkinson's disease and familial Parkinson's disease from Mainland China. Parkinsonism Relat Disord 2010;16(3):235–6.
  • Wang L, Guo JF, Nie LL, et al. A new variant of the ATP13A2 gene in Chinese patients with early-onset parkinsonism. Chin Med J (Engl) 2009;122(24):3082–5.
  • Ning YP, Kanai K, Tomiyama H, et al. PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype. Neurology 2008;70(16 Pt 2):1491–3.
  • Li G, Zhang Z, Xia H, et al. Analysis of Thr12Met and Ala1144Thr mutations of the ATP13A2 Gene in Parkinson's disease patients in Xinjiang Uygur and Han ethnic groups. Med Sci Monit 2014;202177–82.
  • Guo JF, Xiao B, Liao B, et al. Mutation analysis of Parkin, PINK1, DJ-1 and ATP13A2 genes in Chinese patients with autosomal recessive early-onset Parkinsonism. Mov Disord 2008;23(14):2074–9.
  • Wang F, Tuerxun S, Luo J, et al. Correlation between ATP13A2 geen c.2236 G>A polymorphism sites and Parkinson's disease in Uyghur nationality in Hetian Xinjiang. J Xinjiang Med Univ 2013;35(3):283–9.
  • Peeraully T, Tan EK. Genetic variants in sporadic Parkinson's disease: east vs west. Parkinsonism Relat Disord 2012;18(Suppl 1):S63–5.
  • Bonifati V. Autosomal recessive parkinsonism. Parkinsonism Relat Disord 2012;18(Suppl 1):S4–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.